Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.86/Share

November 14, 2016 4:57 PM EST
Get Alerts CYCC Hot Sheet
Trade CYCC Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.86), versus ($0.95) reported last year. Revenue for the quarter came in at $715 thousand, versus $205 thousand reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment